December 8, 2020 | Comments Off on Pharmaceutical Industry Challenges President Trump’s Executive Order Adopting Most Favored Nation Approach
Posted by Frank Ciesla
My December 2, 2020 blog was a discussion of President Trump’s adoption of the Most Favored Nation approach for the pricing of certain drugs in various federal programs. On Friday, the pharmaceutical industry filed suit challenging the decision of the Trump Administration. It will be interesting to see what action, if any, the new President takes to defend the concept or whether the incoming President will walk away from the concept of Most Favored Nation.